SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 196 filers reported holding SAGE THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 0.84 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $451,674 | -30.9% | 9,606 | -44.0% | 0.13% | -51.7% |
| Q4 2022 | $654,025 | +17.0% | 17,148 | -0.9% | 0.26% | -5.7% |
| Q2 2022 | $559,000 | +162.4% | 17,298 | +168.8% | 0.28% | +134.5% |
| Q1 2022 | $213,000 | -27.1% | 6,435 | -2.5% | 0.12% | -35.3% |
| Q3 2021 | $292,000 | -17.7% | 6,597 | -46.6% | 0.18% | -78.1% |
| Q1 2020 | $355,000 | +7.3% | 12,359 | +583.6% | 0.84% | +282.3% |
| Q2 2019 | $331,000 | +22.1% | 1,808 | -46.8% | 0.22% | +134.0% |
| Q2 2017 | $271,000 | – | 3,400 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 475,600 | $15,362,000 | 5.31% |
| Integral Health Asset Management, LLC | 412,257 | $13,316,000 | 2.74% |
| Palo Alto Investors LP | 851,409 | $27,501,000 | 2.40% |
| Boxer Capital, LLC | 1,094,000 | $35,336,000 | 2.24% |
| DAFNA Capital Management LLC | 180,306 | $5,824,000 | 1.59% |
| Ikarian Capital, LLC | 250,000 | $8,075,000 | 1.47% |
| Bellevue Group AG | 2,973,178 | $96,034,000 | 1.36% |
| SECTOR GAMMA AS | 118,476 | $3,827,000 | 0.86% |
| Artal Group S.A. | 450,000 | $14,535,000 | 0.78% |
| Diametric Capital, LP | 19,393 | $626,000 | 0.46% |